Heidenreich, Axel <br/><br/>
Therapies used in prostate cancer patients by European urologists: data on indication with a focus on expectations, perceived barriers and guideline compliance related to the use of bisphosphonates.  [electronic resource] 

 -  Urologia internationalis  2012 
 - 30-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1423-0399 
<br/><br/><label>Standard No.: </label>10.1159/000338810  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--therapeutic use<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Attitude of Health Personnel<br/>Bone Density Conservation Agents--administration & dosage<br/>Bone Neoplasms--drug therapy<br/>Diphosphonates--administration & dosage<br/>Europe<br/>Guideline Adherence--statistics & numerical data<br/>Health Care Surveys<br/>Health Knowledge, Attitudes, Practice<br/>Humans<br/>Internet<br/>Male<br/>Neoplasm Staging<br/>Palliative Care<br/>Patient Selection<br/>Perception<br/>Practice Guidelines as Topic<br/>Practice Patterns, Physicians'--statistics & numerical data<br/>Prostatic Neoplasms--drug therapy<br/>Risk Assessment<br/>Risk Factors<br/>Surveys and Questionnaires<br/>Urology--standards